Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 CAD | -5.16% | -9.82% | -56.12% |
14/05 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.12% | 1.85Cr | |
+64.68% | 6.26TCr | |
-2.01% | 4.12TCr | |
+44.76% | 4.03TCr | |
-8.93% | 2.79TCr | |
+12.77% | 2.62TCr | |
-21.89% | 1.91TCr | |
+3.69% | 1.31TCr | |
+25.96% | 1.23TCr | |
+27.42% | 1.21TCr |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences Brief: Details Executive Management Changes; Announces Resignation of CFO/CBO Jotin Marango; Appoints Philippe Ledru as Chief Commercial Officer